Literature DB >> 33144437

Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.

Tatsuo Kanda1, Reina Sasaki2, Ryota Masuzaki2, Hiroshi Takahashi2, Mariko Fujisawa2, Naoki Matsumoto2, Hiroaki Okamoto3, Mitsuhiko Moriyama2.   

Abstract

BACKGROUND/AIM: Hepatitis A virus (HAV) infection is still one of the serious health problems worldwide, despite the existence of effective vaccines for HAV. Zinc compounds have antiviral activities against various DNA and RNA viruses. Therefore, we investigated the effects of zinc compounds on the antiviral activity of interferon against HAV.
MATERIALS AND METHODS: The effects of zinc compounds with or without interferon on HAV genotype IIIA HA11-1299 replication were examined in human hepatoma Huh7 cells. Cell viability was examined by the MTS assay. Inflammasome associated gene expression was examined by real-time reverse transcription-polymerase chain reaction.
RESULTS: Both zinc sulfate and zinc chloride had an inhibitory effect on HAV replication. Zinc sulfate tended to enhance while zinc chloride significantly enhanced the anti-HAV effect induced by interferon-alpha-2a. Zinc chloride significantly up-regulated mitogen-activated protein kinase 12 (MAPK12) and down-regulated 6 related genes [baculoviral IAP repeat containing 3 (BIRC3), interleukin 1 beta (IL1B), proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1), prostaglandin-endoperoxide synthase 2 (PTGS2), PYD and CARD domain containing (PYCARD), and tumor necrosis factor (TNF)].
CONCLUSION: Zinc chloride inhibits HAV replication and has additive effects on the anti-HAV activities of interferon. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Antivirals; HAV; inflammasomes; interferon; zinc

Mesh:

Substances:

Year:  2020        PMID: 33144437      PMCID: PMC7811611          DOI: 10.21873/invivo.12168

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  39 in total

1.  Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B.

Authors:  Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Yasuhito Tanaka; Noboru Shinkai; Chiaki Okuse; Jong-Hon Kang; Takeshi Matsui; Shiho Miyase; Hiroshi Yatsuhashi; Shinya Nagaoka; Tatsuo Kanda; Masaru Enomoto; Ryoko Yamada; Naoki Hiramatsu; Satoru Saito; Koichi Takaguchi; Kiyoaki Ito; Tsutomu Masaki; Daisuke Morihara; Masataka Tsuge; Kazuaki Chayama; Fusao Ikeda; Tatehiro Kagawa; Yasuteru Kondo; Kazumoto Murata; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2020-07-14       Impact factor: 7.527

2.  Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.

Authors:  Nidhi Kaushik; Chandru Subramani; Saumya Anang; Rajagopalan Muthumohan; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

3.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

4.  A pathogenic picornavirus acquires an envelope by hijacking cellular membranes.

Authors:  Zongdi Feng; Lucinda Hensley; Kevin L McKnight; Fengyu Hu; Victoria Madden; Lifang Ping; Sook-Hyang Jeong; Christopher Walker; Robert E Lanford; Stanley M Lemon
Journal:  Nature       Date:  2013-03-31       Impact factor: 49.962

5.  ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer.

Authors:  Tim D D Somerville; Yali Xu; Xiaoli S Wu; Diogo Maia-Silva; Stella K Hur; Larissa M N de Almeida; Jonathan B Preall; Peter K Koo; Christopher R Vakoc
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 12.779

Review 6.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

7.  Antiviral activity of zinc salts against transmissible gastroenteritis virus in vitro.

Authors:  Zhanyong Wei; Michael Burwinkel; Christiane Palissa; Eden Ephraim; Michael F G Schmidt
Journal:  Vet Microbiol       Date:  2012-06-26       Impact factor: 3.293

8.  Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Kengo Saito; Hiroshi Shirasawa; Tomoko Kiyohara; Koji Ishii; Takaji Wakita; Hiroaki Okamoto; Osamu Yokosuka
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

Review 9.  Japan's Practical Guidelines for Zinc Deficiency with a Particular Focus on Taste Disorders, Inflammatory Bowel Disease, and Liver Cirrhosis.

Authors:  Hiroko Kodama; Makoto Tanaka; Yuji Naito; Kazuhiro Katayama; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

Review 10.  Chaperone-Mediated Autophagy in the Liver: Good or Bad?

Authors:  Srikanta Dash; Yucel Aydin; Krzysztof Moroz
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

View more
  5 in total

1.  Hepatitis A Virus Infection and Molecular Research.

Authors:  Tatsuo Kanda; Reina Sasaki-Tanaka; Shingo Nakamoto
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 2.  Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.

Authors:  Ryota Masuzaki; Tatsuo Kanda; Reina Sasaki; Naoki Matsumoto; Kazushige Nirei; Masahiro Ogawa; Seth J Karp; Mitsuhiko Moriyama; Hirofumi Kogure
Journal:  Cancers (Basel)       Date:  2022-05-22       Impact factor: 6.575

3.  Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan.

Authors:  Masayuki Honda; Hiroyuki Asakura; Tatsuo Kanda; Yoshiko Somura; Tomotaka Ishii; Yoichiro Yamana; Tomohiro Kaneko; Taku Mizutani; Hiroshi Takahashi; Mariko Kumagawa; Reina Sasaki; Ryota Masuzaki; Shini Kanezawa; Kazushige Nirei; Hiroaki Yamagami; Naoki Matsumoto; Mami Nagashima; Takashi Chiba; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

4.  Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients.

Authors:  Momen Askoura; Hisham A Abbas; Hadeel Al Sadoun; Wesam H Abdulaal; Amr S Abu Lila; Khaled Almansour; Farhan Alshammari; El-Sayed Khafagy; Tarek S Ibrahim; Wael A H Hegazy
Journal:  Pathogens       Date:  2022-01-03

Review 5.  Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.

Authors:  Marion Migueres; Sébastien Lhomme; Jacques Izopet
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.